SEC Filing Summary for ADC Therapeutics SA

On June 1, 2026, Ron Squarer, a director at ADC Therapeutics SA, was granted 45,000 restricted stock units (RSUs) under the company's 2019 Equity Incentive Plan. These RSUs are for services as a Director and will vest on the earlier of one year from the grant date or the date of the 2027 Annual Meeting of Shareholders, contingent upon continued service. Each RSU represents a contingent right to one share of the Issuer's common stock. Subsequently, on June 3, 2026, 15,196 shares of Common Stock were withheld by the Issuer to cover the Reporting Person's tax withholding obligations related to the vesting of previously granted RSUs. This transaction resulted in a decrease of shares, with 123,431 shares owned following the transaction. The shares withheld were valued at $3.08 per share.